Popular Articles

Hospitalization Of The Poor Much Higher For Asthma, Diabetes And Other Potentially Preventable Diseases
Hospital admissions of Americans from the poorest communities for asthma and diabetes were 87 percent and 77 percent higher, respectively, than admissions for patients from wealthier areas for the same diseases, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

SPRYCEL(R) (Dasatinib) Shows Potential As Treatment For Prostate Cancer
Bristol-Myers Squibb Company (NYSE: BMY) announced interim results from two Phase II studies of SPRYCEL® (dasatinib) which demonstrate that the medicine may have potential as a treatment for a certain type of advanced prostate cancer.
News of the day
Lack Of Access To Contraception Persists In Nigeria, Study Finds
Nearly one-third of sexually active women ages 15 to 24 in Nigeria had an unmet need for modern contraception in 2003, according to a study from the Guttmacher Institute, BBC News reports. The study, which analyzed health data from Nigerian authorities and non-governmental organizations, found that 16% of pregnancies among women ages 15 to 24 in 2003 were unintended, compared with 10% in 1990. From 1990 to 2003, there was little change -- from 4% to 8% -- in use of modern contraceptives among young women who were sexually active. In addition, the proportion of sexually active young women who were aware of how to access family planning services decreased from 32% in 1990 to 18% in 2003, the study found. The study also said that although the proportion of girls and young women with some secondary education increased from 34% in 1990 to 50% in 2003, Nigerian authorities have inadequately promoted sexual health information, including contraceptive information, to the country"s youth. The report noted that Nigeria"s population is increasing by 2.2% annually and will double every 32 years if that rate is maintained.Friday Okonofua, the co-author of the report, said, "We are failing Nigerian adolescents when it comes to providing them with the information and services they need to delay marriage and avoid unintended pregnancies." She added that the lack of information leaves girls and young women vulnerable to unintended pregnancies and sexually transmitted infections like HIV (BBC News, 6/16).
Oncology

FDA Warns Consumers Not To Use Skin Products Made By Clarcon Due To Bacterial Contamination Risk

The U.S. Food and Drug Administration announced that Clarcon Biological Chemistry Laboratory Inc. of Roy, Utah, is voluntarily recalling some skin sanitizers and skin protectants marketed under several different brand names because of high levels of disease-causing bacteria found in the product during a recent inspection. The FDA is warning consumers to not use any Clarcon products. Consumers should not use any Clarcon products and should throw these products away in household refuse. Analyses of several samples of over-the-counter topical antimicrobial skin sanitizer and skin protectant products revealed high levels of various bacteria, including some associated with unsanitary conditions. Some of these bacteria can cause opportunistic infections of the skin and underlying tissues. Such infections may need medical or surgical attention, and may result in permanent damage. Examples of products that should be discarded include: - Citrushield Lotion - Dermasentials DermaBarrier - Dermassentials by Clarcon Antimicrobial Hand Sanitizer - Iron Fist Barrier Hand Treatment - Skin Shield Restaurant - Skin Shield Industrial - Skin Shield Beauty Salon Lotion - Total Skin Care Beauty - Total Skin Care Work Findings from the FDA"s recent inspection of the Clarcon facility are particularly concerning because the products are promoted as antimicrobial agents that claim to treat open wounds, damaged skin, and protect against various infectious diseases. The inspection uncovered serious deviations from FDA"s current Good Manufacturing Practice requirements. U.S. Food and Drug Administration


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):